Heart failure (HF) represents a major health and economic issue, with increasing morbidity and mortality in spite of novel therapeutic weapons. The disappointing results of HF management may be due to the current thera-peutic approach based on the paradigm "one fits all", that cannot apply to a complex and multifaceted syndrome as HF. At this regard, the European Union is developing policies to move from reductionism to precision med-icine, in order to identify specific disease biomarkers and develop targeted therapeutic strategies. The institution of biobanks may represent the game changer in HF scenario, providing a collection of human biological materials with the related medical and epidemiological data fueling the development of personalized therapeutic approach and fostering current and/or future research projects.

Biobanks: the unmet need in heart failure management / Manzi, Giovanna; Mariani, Marco Valerio; Filomena, Domenico; Poscia, Roberto; Severino, Paolo; Iaconelli, Antonio; Recchioni, Tommaso; Madonna, Rosalinda; Vizza, Carmine Dario; Badagliacca, Roberto. - In: VASCULAR PHARMACOLOGY. - ISSN 1537-1891. - 150:(2023). [10.1016/j.vph.2023.107179]

Biobanks: the unmet need in heart failure management

Manzi, Giovanna;Mariani, Marco Valerio;Filomena, Domenico;Poscia, Roberto;Severino, Paolo;Recchioni, Tommaso;Vizza, Carmine Dario;Badagliacca, Roberto
2023

Abstract

Heart failure (HF) represents a major health and economic issue, with increasing morbidity and mortality in spite of novel therapeutic weapons. The disappointing results of HF management may be due to the current thera-peutic approach based on the paradigm "one fits all", that cannot apply to a complex and multifaceted syndrome as HF. At this regard, the European Union is developing policies to move from reductionism to precision med-icine, in order to identify specific disease biomarkers and develop targeted therapeutic strategies. The institution of biobanks may represent the game changer in HF scenario, providing a collection of human biological materials with the related medical and epidemiological data fueling the development of personalized therapeutic approach and fostering current and/or future research projects.
2023
biobanks; heart failure; precision medicine
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Biobanks: the unmet need in heart failure management / Manzi, Giovanna; Mariani, Marco Valerio; Filomena, Domenico; Poscia, Roberto; Severino, Paolo; Iaconelli, Antonio; Recchioni, Tommaso; Madonna, Rosalinda; Vizza, Carmine Dario; Badagliacca, Roberto. - In: VASCULAR PHARMACOLOGY. - ISSN 1537-1891. - 150:(2023). [10.1016/j.vph.2023.107179]
File allegati a questo prodotto
File Dimensione Formato  
Manzi_Biobanks_2023.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 342.61 kB
Formato Adobe PDF
342.61 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1686951
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact